Posts in category Healthcare


AEterna Zentaris Inc. (USA) Announces Replacement At the Market Issuance Program

AEterna Zentaris Inc. (USA) (NASDAQ:AEZS) announced that it has entered into a new At Market …

Read more

CytRx Corporation (CYTR) Shares Take a Hit on Share Dilution

CytRx Corporation (NASDAQ:CYTR) shares tank 20% to $0.55 in pre-market trading Friday, after the drug maker announced that …

Read more

Vertex Pharmaceuticals Incorporated (VRTX) Announces Q1:17 Financial Results

Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) reported consolidated financial results for the quarter ended March 31, 2017. Vertex also …

Read more

Sarepta Therapeutics Inc (SRPT) Reports Q1:17 Financial Results

Sarepta Therapeutics Inc (NASDAQ:SRPT) reported financial results for the first quarter of 2017. “The first …

Read more

Celgene Corporation (CELG) Shares Slip; Here’s Why

Celgene Corporation (NASDAQ:CELG) shares are down nearly 2% this morning, after the drug giant reported mixed first-quarter …

Read more

Cellectar Biosciences Inc (CLRB) Climbs on Positive Preclinical Data in Solid Tumors

Cellectar Biosciences Inc (NASDAQ:CLRB) announces preclinical data that demonstrate the utility of the company’s lead compound, …

Read more

Biopharmx Corp (BPMX) Shares Dip on Share Dilution

Biopharmx Corp (NYSEMKT:BPMX) investors are heading for the hills after the healthcare firm announced that …

Read more

Akebia Therapeutics Inc (AKBA) Shares Take Off on Expanded Deal with Otsuka

It’s a very rewarding trading day for investors in Akebia Therapeutics Inc (NASDAQ:AKBA), with shares …

Read more

Valeant Pharmaceuticals Intl Inc’s (VRX) Bausch + Lomb Announces 510(k) Clearance from FDA For Vitesse

Valeant Pharmaceuticals Intl Inc’s (NYSE:VRX) wholly owned subsidiary, Bausch + Lomb, announced it has received …

Read more

Cellectar Biosciences Inc (CLRB) Granted Additional U.S. Patents Covering the Use of PDC Optical Agents

Cellectar Biosciences Inc (NASDAQ:CLRB) announces the United States Patent and Trademark Office has granted a …

Read more